Press releases

Month Year

Email alerts

Oct 5, 2020

Medtronic Announces Virtual 2020 Institutional Investor and Analyst Event and Webcast

Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Event on Wednesday, October 14, 2020, from 8:00 a.m. to approximately 2:00 p.m....
Oct 1, 2020

Medtronic Resolute Onyx™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy...
Sep 30, 2020

Medtronic to Acquire Avenu Medical

Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with...
Sep 29, 2020

Medtronic Announces Closing of Public Offering of €6.25 Billion of Senior Notes and Redemption of Outstanding Senior Notes

Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ("Medtronic Luxco") has closed a registered public offering (the...
Sep 25, 2020

Medtronic Gets Affirmation of Key Sacral Neuromodulation Patent

U.S. Patent and Trademark Office Rejects IPR Challenge to Medtronic Patent

Medtronic (NYSE:MDT) has won an important victory in a patent dispute over intellectual property for its sacral neuromodulation device family, the InterStim™ systems. The Patent Trial and Appeal...

Show per page